DermOne of North Carolina — Wilmington, North Carolina

DermOne of North Carolina is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

DermOne of North Carolina has participated in 1 clinical trials.

Therapeutic areas: Actinic Keratosis.

Sponsors: Teva Pharmaceuticals USA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in North Carolina · View every site in Wilmington

• New Hanover Regional Hospital
• Betty Cameron Women & Children's Hospital
• PMG Research of Wilmington
• Research Site
• GSK Investigational Site
• Trial Management Associates
• New Hanover Regional Medical Center
• Accellacare
• Novant Health New Hanover Regional Medical Center
• Accellacare-Wilmington
• Novo Nordisk Investigational Site
• Wilmington Dermatology Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DermOne of North Carolina?

DermOne of North Carolina has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DermOne of North Carolina conducted?

DermOne of North Carolina has 1 clinical trials on record. Their work covers Actinic Keratosis.

Is DermOne of North Carolina accredited by Crixeo Clinical Trials?

DermOne of North Carolina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DermOne of North Carolina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.